ArticleEuropean geriatric medicine2026
Providing insight in resilience and recovery by using fatigability and its development over time in older adults after hip fracture surgery.
Article in European geriatric medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeOlder hip fracture patients are often frail, complicating their recovery trajectories. Insight into patients' resilience may help in getting more understanding of their predicted recovery and adjusting their treatment plan accordingly. This study aims to assess if fatigability, calculated with the Capacity to Perceived Vitality ratio (CPV), at baseline and its development over time, can provide insight into recovery and resilience at hospital discharge.
methodsIn this prospective cohort study, patients were included from March 2022 to February 2024. Growth modelling was used to test whether there was a change in CPV over time during hospitalization and which covariables were associated with CPV. Subsequently, two logistic regression analyses were conducted to assess the role of CPV as a predictor of mobility at discharge (FAC score) and hospital complications (yes/no).
resultsCPV did not significantly change over time (estimate = 0.99; 95%CI 0.90-1.10). At baseline, men had a factor 1.6 (p = 0.01) higher CPV than women and patients with a pre-fracture KATZ-ADL 6 score of 0 had a factor 2.1 (p = 0.003) higher CPV than patients with a pre-fracture KATZ-ADL 6 score of 2 or more. The logistic regression models showed that when the intercept of CPV increased, the odds of a dependent FAC score at discharge (p = 0.002) and of developing a complication (p = 0.037) decreased.
conclusionCPV at baseline had predictive value for mobility at discharge and complications during hospitalization. Furthermore, there was no significant change in CPV over time, and the covariables gender and pre-fracture KATZ-ADL 6 mainly influenced the CPV at baseline.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.